• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
  • ABOUT US
    • Presentation
    • People
    • Contact
  • Spanish
  • English

HERA secures up to 2 million doses of the monkeypox vaccine

Inicio » EU News » Health » Diseases » HERA secures up to 2 million doses of the monkeypox vaccine

18 de November de 2022

The Commission’s Health Preparedness and Response Authority (HERA), has signed a Joint Procurement Framework contract with the company Bavarian Nordic, for the supply of up to 2 million doses of the monkeypox vaccine in the course of 2023 and 2024.

manos sujetan una jeringuilla y una dosis de una vacuna

This offers 14 participating countries the possibility to purchase doses to address their medium- and long-term needs and build stockpiles. The first deliveries under the joint procurement of the vaccine doses will start in the second quarter of 2023.

The Commission remains focused on preventing monkeypox from becoming endemic in Europe, as outlined in a joint statement by the Commissioner for Health and Food Safety, Stella Kyriakides, and WHO Regional Director for Europe, Dr Hans Henri P. Kluge.

Evolution of monkeypox in Europe

 

While the Joint Procurement contract signed with Bavarian Nordic intends to meet the middle and long-term needs of participating countries, it complements the work over recent months by HERA and the European Health and Digital Executive Agency (HaDEA) to procure over 334,000 vaccine doses to cover the immediate needs of Member States, using EU funds for the first time. This is also in addition to the purchase of over 10,000 doses of tecovirimat, a treatment for monkeypox.

Background

The EU’s mechanism of joint procurement is laid down in the EU’s Joint Procurement Agreement, which is signed by 36 countries. The mechanism allows to jointly procure medical countermeasures as an alternative or complement to procurement at national level.

It secures a more equitable access to specific medical countermeasures and improves the security of supply, together with more balanced prices for the participating EU countries.

Considerations for contact tracing during the monkeypox outbreak in Europe, 2022

 

 

When at least 4 of the 36 participating countries are interested to jointly procure a medical countermeasure, HERA may launch the procurement procedure. For the joint purchase of the monkeypox vaccine, announced today, 14 Member States are participating.

HERA continues to work closely with the participating countries to identify and implement priorities, such as vaccines or therapeutics, for joint procurement.

More information: European Commission – Press release

Publicaciones relacionadas:

European Commission unveils EU vaccines strategy European Commission authorises second safe and effective vaccine against COVID-19 manos sujetan una jeringuilla y una dosis de una vacunaHERA signs Joint Procurement contract for Pandemic Influenza Vaccine EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca EU urges AstraZeneca to explain vaccine delivery delays

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

European Commission unveils EU vaccines strategy European Commission authorises second safe and effective vaccine against COVID-19 manos sujetan una jeringuilla y una dosis de una vacunaHERA signs Joint Procurement contract for Pandemic Influenza Vaccine EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca EU urges AstraZeneca to explain vaccine delivery delays

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. </p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información